Genzyme Temporarily Stops Production At Allston Plant
Published: 16-Jun-2009
Expects to be fully operational by the end of July
Genzyme has detected a virus that impairs cell growth in one of six bioreactors at Allston Landing manufacturing facility. So, the company has decided to temporarily stop bulk production at the plant to sanitize the facility.
The company expects the plant to be fully operational by the end of July.
The virus strain, Vesivirus 2117 found, is known to interfere with the growth of CHO cells used to produce biologic drugs, and was likely introduced through a nutrient used in the manufacturing process.
Genzyme is adding steps to increase the robustness of raw materials screening and viral removal processes.
Henri Termeer, Chairman and CEO of Genzyme, said: “We are confident in the quality of the products produced in Allston and in our ability to resolve the issue affecting the plant. The impact will be temporary.”
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
